Is nocturnal asthma caused by changes in airway cholinergic activity?
A randomised, double blind, placebo controlled crossover trial of high dose nebulised ipratropium was carried out in 10 asthmatic patients with documented nocturnal bronchoconstriction. Patients received nebulised saline or ipratropium 1 mg at 10 pm and 2 am on two nights. Absolute peak flow (PEF) r...
Uloženo v:
| Vydáno v: | Thorax |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Publishing Group
1988
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC461462/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2973665/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/thx.43.9.720 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
